Lindbrook Capital »

Aquestive Therapeutics shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $543 109 4.98

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Golub Cap Bdc Cef (GBDC)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)
Vanguard Growth Etf Etf (VUG)

View all positions for Lindbrook Capital

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
VR Adviser
BlackRock
Vanguard Group
Franklin Resources
Geode Capital Management
Blue Owl Capital Holdings
Citadel Advisors
State Street Corporation
Janney Montgomery Scott
Woodline Partners
Invesco
Nuveen Asset Management
Susquehanna International

View all funds holding Aquestive Therapeutics